Portfolio
Professional & Aesthetic · Plant-derived EVs

ExoCura

A botanical extracellular-vesicle platform for professional skincare and formulation, isolated from selected edible botanicals under one release standard.

  • 2.5 × 109 particles / mL — batch-verified concentration
  • 50–200 nm cup-shaped vesicles; PDI < 0.3 (monodisperse)
  • Exosomal markers HSP70 & HSP90 confirmed by Western blot
  • Sterile · mycoplasma-negative · endotoxin < 0.5 EU/mL
Request a Dossier See how we characterize
ExoCura
ExoCura · Plant-derived EVs
01SpecificationsThe full spec sheet
Classification
Plant-derived extracellular vesicles (cosmetic ingredient)
Intended use
Professional skincare formulation and product development
Not intended for
Injection, systemic administration, or treating disease
Source material
Edible botanicals: turmeric, centella asiatica, blueberry, goji, ginger
Concentration
2.5 × 109 particles/mL (≈ 2.5 billion exosomes / cc)
Particle size
50–200 nm (NTA mode; Z-average within range)
Polydispersity
PDI < 0.3 — monodisperse
Morphology
Cup-shaped vesicles (TEM)
Markers
HSP70, HSP90 positive by Western blot
Protein
0.5–5 mg/mL (BCA assay)
Endotoxin
< 0.5 EU/mL (LAL assay)
Sterility
No bacterial or fungal growth · mycoplasma-negative
pH (reconstituted)
6.5–7.5
Appearance
Clear to slightly opalescent liquid; free of visible particulates
Formats
2B / vial · 5 mL
Storage
Store at −20 °C or below; avoid repeated freeze–thaw
Shelf life
12 months from production; stated on each Certificate of Analysis
Minimum order
On request by market
Lead time
Confirmed with each quote
02Release panelEvery batch, this analytical panel

Analytical release,
on the record.

A representative Certificate of Analysis for batch ExoCura-PE2601. Every ExoCura lot ships with its own signed CoA — identical tests, batch-specific values.

GainMed
CERTIFICATE OF ANALYSIS
Batch ExoCura-PE2601
Prod. 20 Jan 2025 · Exp. 20 Jan 2026
ExoCura · Plant-derived exosomes (liquid)

Characterization & release

Particle size — modeNanoparticle Tracking Analysis (NTA)
50–200 nm
Pass
Particle concentrationNTA
2.5 × 109 /mL
Pass
MorphologyTransmission Electron Microscopy (TEM)
Cup-shaped
Pass
Polydispersity indexPDI — monodispersity
< 0.3
Pass
Identity markersWestern blot · HSP70 / HSP90
Positive
Pass
Protein concentrationBCA assay
0.5–5 mg/mL
Pass
EndotoxinLAL assay
< 0.5 EU/mL
Pass
SterilityBacterial & fungal culture
No growth
Pass
MycoplasmaqPCR
Not detected
Pass
pH (reconstituted)USP <791>
6.5–7.5
Pass
Released by QA Request the full CoA
03DocumentationWhat ships with each batch

Documentation
available.

Request any of the following for ExoCura. We share what applies to your market and intended use.

  • White paperon request
  • Product overviewon request
  • Characterization data (NTA / TEM)on request
  • Quality informationon request
  • Handling guideon request

Cosmetic classification

ExoCura is supplied as a cosmetic ingredient for professional formulation. It is for external use on intact skin and is not intended to diagnose, treat, cure, or prevent any disease. Plant-derived extracellular vesicles fall outside human-tissue frameworks; availability and labeling requirements vary by market.

04Also in the portfolioRelated materials
Cream & Serum

Apexium

Professional & Aesthetic

 Human UMSC-derived

ExoCell

Clinical Materials

 Stem-cell materials

WJ-MSCs

Clinical Materials

Request ExoCura.

Tell us your market and intended use. A specialist replies within one business day.

Request a Dossier